PATENT CLAIM ANALYSIS

Application Number: 16291401
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-06
Patent Classification: ["514", "394000"]

Abstract:
Methods of treatment using bendamustine formulations designed for small volume intravenous administration are disclosed. The methods conveniently allow shorter administration time without the active ingredient coming out of solution as compared to presently available formulations.

Claim (Index 15):
The method of  claim 14 , wherein the method is repeated for up to 8 cycles.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 99.0
- Lexical Diversity: 1.12121
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14714578', '15184464', '15184488', '13838090', '15008819']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7948243469590711
- 35 USC 102 Novelty (BERT): 0.557585110940004
- Combined Prediction Score: 0.7711004233571644
- Mean Citation Score: 411.256314
- Max Citation Score: 416.11646
- Similarity Product: 307.72558196043485

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test